Search research articles
Contact Us
Filters
Showing results (91-100 of 124) with videos related to
Page
of 13
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2010
Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial
V Hess, S Pratsch, S Potthast, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 18, 2011
PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference
Melpomeni Fani, Luigi Del Pozzo, Keelara Abiraj, et al.
Frontiers of Hormone Research
|
July 10, 2010
iASPP: a novel protein involved in pituitary tumorigenesis?
Emilia M Pinto, Nina Rosa C Musolino, Valter A S Cescato, et al.
Chemistry & Biodiversity
|
December 12, 2013
Syntheses, receptor bindings, in vitro and in vivo stabilities and biodistributions of DOTA-neurotensin(8-13) derivatives containing β-amino acid residues - a lesson about the importance of animal experiments
Christof Sparr, Nirupam Purkayastha, Tomohiro Yoshinari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 4, 2006
Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists
Renzo Cescato, Stefan Schulz, Beatrice Waser, et al.
Pituitary
|
April 7, 2023
How to manage intolerance to dopamine agonist in patients with prolactinoma
Matheo Augusto Morandi Stumpf, Felipe Moura Maia Pinheiro, Gilberto Ochman Silva, et al.
World Neurosurgery
|
August 24, 2018
Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile
Rafael Loch Batista, Ericka Barbosa Trarbach, Mateus Diniz Marques, et al.
Chemistry & Biodiversity
|
May 12, 2011
On the terminal homologation of physiologically active peptides as a means of increasing stability in human serum--neurotensin, opiorphin, B27-KK10 epitope, NPY
Dieter Seebach, Aneta Lukaszuk, Krystyna Patora-Komisarska, et al.
International Archives of Otorhinolaryngology
|
July 10, 2015
Thickened Pituitary Stalk Associated with a Mass in the Sphenoidal Sinus: An Alarm to Suspect Hypophysitis by Immunoglobulin G4?
Rafael Loch Batista, Luciano Silva Ramos, Valter Angelo Cescato, et al.
European Journal of Endocrinology
|
April 23, 2008
Association between tumoral GH-releasing peptide receptor type 1a mRNA expression and in vivo response to GH-releasing peptide-6 in ACTH-dependent Cushing's syndrome patients
Marcio Carlos Machado, Sandra Valeria de Sa, Maria Lucia Correa-Giannella, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 124) with videos related to
Sort By:
Page
of 13
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2010
Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial
V Hess, S Pratsch, S Potthast, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 18, 2011
PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference
Melpomeni Fani, Luigi Del Pozzo, Keelara Abiraj, et al.
Frontiers of Hormone Research
|
July 10, 2010
iASPP: a novel protein involved in pituitary tumorigenesis?
Emilia M Pinto, Nina Rosa C Musolino, Valter A S Cescato, et al.
Chemistry & Biodiversity
|
December 12, 2013
Syntheses, receptor bindings, in vitro and in vivo stabilities and biodistributions of DOTA-neurotensin(8-13) derivatives containing β-amino acid residues - a lesson about the importance of animal experiments
Christof Sparr, Nirupam Purkayastha, Tomohiro Yoshinari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 4, 2006
Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists
Renzo Cescato, Stefan Schulz, Beatrice Waser, et al.
Pituitary
|
April 7, 2023
How to manage intolerance to dopamine agonist in patients with prolactinoma
Matheo Augusto Morandi Stumpf, Felipe Moura Maia Pinheiro, Gilberto Ochman Silva, et al.
World Neurosurgery
|
August 24, 2018
Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile
Rafael Loch Batista, Ericka Barbosa Trarbach, Mateus Diniz Marques, et al.
Chemistry & Biodiversity
|
May 12, 2011
On the terminal homologation of physiologically active peptides as a means of increasing stability in human serum--neurotensin, opiorphin, B27-KK10 epitope, NPY
Dieter Seebach, Aneta Lukaszuk, Krystyna Patora-Komisarska, et al.
International Archives of Otorhinolaryngology
|
July 10, 2015
Thickened Pituitary Stalk Associated with a Mass in the Sphenoidal Sinus: An Alarm to Suspect Hypophysitis by Immunoglobulin G4?
Rafael Loch Batista, Luciano Silva Ramos, Valter Angelo Cescato, et al.
European Journal of Endocrinology
|
April 23, 2008
Association between tumoral GH-releasing peptide receptor type 1a mRNA expression and in vivo response to GH-releasing peptide-6 in ACTH-dependent Cushing's syndrome patients
Marcio Carlos Machado, Sandra Valeria de Sa, Maria Lucia Correa-Giannella, et al.
Page
of 13